Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: Rationale for combination treatment during arthritis (Q58998934)
Jump to navigation
Jump to search
scholarly article by Marije I. Koenders et al published August 2011 in Arthritis and Rheumatism
- Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: Rationale for combination treatment during arthritis |
scholarly article by Marije I. Koenders et al published August 2011 in Arthritis and Rheumatism |
|
Statements
Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: Rationale for combination treatment during arthritis (English)
0 references
Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis (English)
0 references
August 2011
0 references
63
0 references
8
0 references
2329-2339
0 references
2329-39
0 references